By inferring the ancestral tumor genome, we identified a subset of somatic mutations that play an important role in the early stages of tumor progression, including an early driver mutation in TP53. These data provide new insight into genome evolution in breast cancer and would not have been revealed by sequencing the bulk tumor en masse. This evidence concerns the gene TP53 and breast carcinoma.